Quest Diagnostics Inc
(NYSE: DGX)
-0.20
-0.32%
Quest Diagnostics Inc, a mid-cap value company in the health care sector, is expected to match the market over the next six months with less than average risk.
10 is the best possible rating.
The StockScouter measure of relative price change and consistency is high. Positive
Previous day's closing price for DGX was slightly above its 50-day moving average. Positive
ConThe most recent quarterly earnings report was significantly lower than analysts' consensus forecast. Negative
One or more analysts has modestly decreased quarterly earnings estimates for DGX. Negative
The most recent quarterly earnings report was significantly lower than analysts' consensus forecast. Negative
Earnings growth in the past year has decelerated rapidly compared to earnings growth in the past three years. Negative
One or more analysts has modestly decreased quarterly earnings estimates for DGX. Negative
Executives, board directors or major shareholders have bought and sold shares recently. Neutral
Shares are under heavy accumulation by financial institutions. Positive for large companies like DGX
The price-to-earnings multiple is close to the average for all stocks in the StockScouter universe. Neutral
The price-to-sales multiple is about the same as the average for all stocks in the StockScouter universe. Neutral for a medium- to large-sized company like DGX
The ratio of DGX's price-to-earnings multiple to its five-year growth rate is above the average of all stocks in the StockScouter universe. Negative
The StockScouter measure of relative price change and consistency is high. Positive
Previous day's closing price for DGX was slightly above its 50-day moving average. Positive
data provided by Verus Analytics
Learn more about the StockScouter rating system.
Page generated 6/19/2013 2:54 AM ET
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
